Variant report
Variant | nsv525037 |
---|---|
Chromosome Location | chr9:118078006-118081458 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:118072207..118074478-chr9:118077009..118079074,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs527776156 | chr9:118079037-118079038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147129022 | chr9:118079059-118079060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs58010560 | chr9:118079070-118079071 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs533181085 | chr9:118079085-118079086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550412996 | chr9:118079088-118079089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140296347 | chr9:118079092-118079093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188195422 | chr9:118079109-118079110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536171523 | chr9:118079113-118079114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375370813 | chr9:118079128-118079129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555522937 | chr9:118079131-118079132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182026354 | chr9:118079133-118079134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368000672 | chr9:118079151-118079152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs142084852 | chr9:118079199-118079200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115294899 | chr9:118079251-118079252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577527142 | chr9:118079391-118079392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558794140 | chr9:118079460-118079461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543067649 | chr9:118079481-118079482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557194735 | chr9:118079503-118079504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112239338 | chr9:118079520-118079521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542942639 | chr9:118079534-118079535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570613533 | chr9:118079573-118079574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78733841 | chr9:118079581-118079582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537959616 | chr9:118079590-118079591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs35331883 | chr9:118079611-118079612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528298693 | chr9:118079615-118079616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs371498571 | chr9:118079761-118079762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs116753439 | chr9:118079770-118079771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs964631 | chr9:118079772-118079773 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs75888377 | chr9:118079789-118079790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541835201 | chr9:118079823-118079824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187265456 | chr9:118079888-118079889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552336111 | chr9:118079900-118079901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs73656745 | chr9:118079908-118079909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369444196 | chr9:118079911-118079912 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549316182 | chr9:118079925-118079926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs386737912 | chr9:118079943-118079944 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs114468921 | chr9:118079944-118079945 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368853620 | chr9:118080038-118080039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111564195 | chr9:118080070-118080071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537178789 | chr9:118080086-118080087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141116290 | chr9:118080107-118080108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573627256 | chr9:118080108-118080109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs149818851 | chr9:118080129-118080130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs553312204 | chr9:118080148-118080149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573493264 | chr9:118080222-118080223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73563101 | chr9:118080225-118080226 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs371838675 | chr9:118080231-118080232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs375803007 | chr9:118080277-118080278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181635220 | chr9:118080301-118080302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559250782 | chr9:118080360-118080361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 19147751 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Bladder cancer | 21909424 | CNVD |
Breast cancer | 21509527 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Cervical cancer | 16585170 | CNVD |
Ependymoma | 19289631 | CNVD |
Schizophrenia | 18940311 | CNVD |
Neuroticism | 17667963 | CNVD |
Cervical cancer | 17311676 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Neurodevelopmental disorder | 0 | CNVD |
Amyotrophic lateral sclerosis | 20685689 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:118079000-118080000 | Enhancers | Osteobl | bone |
2 | chr9:118079800-118081400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr9:118081400-118081600 | ZNF genes & repeats | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |